Author

J. Khatun

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

A. A. Chakraborty· 1 shared A. A. Hakimi· 1 shared A. Singh· 1 shared C. J. Weight· 1 shared C. Salem· 1 shared C. Tang· 1 shared C. Zhao· 1 shared D. A. Orlando· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Chakraborty

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The SLC1A1/EAAT3 Dicarboxylic Amino Acid Transporter is an Epigenetically Dysregulated Nutrient Carrier that Sustains Oncogenic Metabolic Programs

T. M. Grubb, J. Khatun, S. Matar, F. Ghandour, N. Dubasik, C. Salem, D. A. Orlando, M. G. Guenther, S. R. Martinez, P. Koochaki, J. A. Coker, C. Tang, E. Reznik, R. R. Kotecha, A. A. Hakimi, , A. A. Chakraborty

This study identifies SLC1A1/EAAT3 as an oncogenic transporter in ccRCC driven by H3K27ac, showing its role in sustaining metabolic programs and its potential as a therapeutic target.

bioRxiv · Sep 4, 2023 · PreprintCancer Biology

A therapeutically targetable NOTCH1-SIRT1-KAT7 axis in T-cell Leukemia

O. Lancho, A. Singh, V. da Silva-Diz, L. Tottone, P. Renck Nunes, M. Aleksandrova, J. Khatun, S. Luo, C. Zhao, H. Zheng, E. Chiles, Z. Zuo, P. P. Rocha, X. Su, H. Khiabanian, D. Herranz

This paper identifies a NOTCH1-SIRT1-KAT7 axis in T-ALL that promotes leukemia and resistance to therapy, suggesting new therapeutic targets.

bioRxiv · May 21, 2022Cancer Biology